A study of changes in insulin requirements related to the menstrual cycle in Japanese women with type 1 diabetes using the advanced hybrid closed‐loop system
Oct 2026· Journal of Diabetes Investigation· 0 citations· 26 references
Medicine
TL;DR
During AHCL therapy, insulin requirements increased and glycemic control modestly worsened in the late‐luteal phase, and no clear associations between phase‐related metabolic changes and menstrual symptom scores or PMDD screening status were detected in this small cohort.
Abstract
ABSTRACT Aims/Introduction In type 1 diabetes (T1D), insulin requirements and glycemic control may vary across the menstrual cycle. We examined phase‐related differences in insulin requirements, glycemic metrics, and recorded carbohydrate amounts in women using an advanced hybrid closed‐loop (AHCL) system and their associations with menstrual symptoms and premenstrual dysphoric disorder (PMDD) screening status. Materials and Methods Fifteen premenopausal women with T1D using the MiniMed 780G without hormonal therapy were analyzed. Cycles with ≥2 eligible days (SmartGuard ≥70%) in both early follicular (d1–7) and late‐luteal (d‐7 to −1) phases were included. Phase differences were assessed using linear mixed‐effects models. Associations between phase‐related changes and menstrual symptom scores and PMDD screening status were evaluated using Spearman correlation and the Mann–Whitney U test, respectively. Results Eighty cycles were analyzed. Compared with the early follicular phase, the late‐luteal phase showed a higher total daily insulin dose (49.2 ± 3.7 vs 45.1 ± 3.7 U/day), basal insulin dose, total bolus insulin, and recorded carbohydrate amount (197.9 ± 18.2 vs 186.1 ± 18.2 g/day), with lower Time in Range (70.0 ± 3.2% vs 72.9 ± 3.2%) and higher Time above Range (TAR). Most phase‐related differences persisted after adjustment for recorded carbohydrate amount. No clear associations between menstrual symptom scores or PMDD screening status and phase‐related changes were detected. Conclusion During AHCL therapy, insulin requirements increased and glycemic control modestly worsened in the late‐luteal phase. No clear associations between phase‐related metabolic changes and menstrual symptom scores or PMDD screening status were detected in this small cohort.
Hormonal fluctuations during the menstrual cycle affect insulin sensitivity, yet their impact on CGM outcomes in adolescents with type 1 diabetes (T1D) is poorly characterised. Whether automated insulin delivery (AID) compensates for cycle-related variability is not estabished in big cohorts.
To assess the...
C. Nobili, G. Prandi, B. Bombaci et al.· Hormone Research in Paediatr...· 0 citations
Hormonal fluctuations across the menstrual cycle may alter insulin sensitivity in girls with type 1 diabetes (T1D). In adolescents using automated insulin delivery (AID), these effects may be underestimated if glucose metrics remain stable because the system compensates through insulin delivery.
To assess...
C. Antas, M. Afonso, C. D. de Almeida et al.· Hormone Research in Paediatr...· 0 citations
Objective. Blood Glucose regulation is thought to vary across the menstrual cycle, however, current evidence is insufficient. Here, we characterized menstrual cycle-aligned variation in glucose using CGM-derived metrics, postprandial glucose responses, and dietary intake in women without diabetes. Research Design and M...
S. Aharoni, A. Godneva, R. Shaulitch et al.· medRxiv· 0 citations
Introduction Multi-ingredient nutritional supplements combining insulin-sensitizing and anti-androgenic compounds are increasingly used in polycystic ovary syndrome (PCOS), yet evidence on their combined clinical effects remains limited. This study aimed to evaluate whether the use of a multi-ingredient nutritional sup...
Aya Abdelrazzak, Firas K. Salman, Ahmad Hammoud et al.· Cureus· 0 citations
T1D is a challenging condition, especially for women, who may have difficulties managing glucose levels during the luteal phase of the menstrual cycle. The association of food craving, carb intake, and glucose levels in AID users remains unknown.
To evaluate food cravings, carb intake, glucose, and insulin...
F. Giraudo, C. Campusano, M. T. Onetto et al.· Hormone Research in Paediatr...· 0 citations
The moderate MET group showed the largest numerical HbA1c reduction, although between-subgroup differences were not statistically significant, which support evidence-based exercise prescription in this population, though further research is needed to clarify dose–response relationships and long-term outcomes.
Nian-Xin Kong, Ming-Yi Liu, Hai-Pei Gong et al.· Frontiers in Nutrition· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.